Grants and Contributions

As part of the international consortium project “UK Biomanufacturing - 10143578 - NPmsDNA2024 - Development of in vivo targeted non-viral gene therapies”, this project's objective is to use Chromatin Bio's bioinformatics platform to design novel gene regulatory elements, improving gene expression in Mediphage therapeutic constructs for Stargardt disease, while reducing sequence complexity and increasing manufacturing yields. Once generated, these constructs will be complexed with Entos proprietary ocular nanocarrier for in vivo evaluation by NRC and Entos. The best performing candidates will then be manufactured as msDNA drug substances for further therapeutic development.

Capital costs to expand a facility for training and the demonstration and commercialization of mining and dual-use technologies.

This contribution supports the Nature Conservancy of Canada in the establishment of two protected areas: Kitaskinaw Indigenous Protected and Conserved Area in Manitoba and the proposed national park in Teetłit Gwinjik (Peel River) Watershed, Yukon. This includes facilitating dialogue among parties, providing technical and conservation-planning expertise, and helping identify strategies or mechanisms to resolve mineral claims as part of the park establishment process.

Community Engagement

The project would modernize a community facility into a multi-use space by expanding program capacity, improving accessibility, adding co-working and meeting spaces, creating innovation labs and an Indigenous Knowledge Centre.

Community Engagement

Community Engagement

Community Engagement

Community Engagement

Community Engagement